Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

Uber A Step Closer To Buying Middle Eastern Rival Careem

Published 12/29/2019, 09:51 PM
Updated 07/09/2023, 06:31 AM

Uber Technologies (NYSE:UBER) has moved a step closer to buying Dubai-based firm, Careem, following the conditional approval of the same from Egyptian regulator — the Egyptian Competition Authority (“ECA”).

Notably, Uber, based in San Francisco, CA, inked a deal to acquire Careem — a provider of ridesharing, meal delivery and payment services across the Middle East, North Africa and Pakistan — for a total consideration of roughly $3.1 billion. Out of $3.1 billion, approximately $1.4 billion will be in cash and the balance will be paid through non-interest-bearing unsecured convertible notes. Notably, both Uber, which competes with the likes of Lyft (NASDAQ:LYFT) in the ride-hailing space, and Careem have operated in Egypt since 2014.

The deal, announced in March, is expected to close in January 2020. Following the closure, Careem will become a wholly-owned subsidiary of Uber. However, it will continue to function with independent management and as an independent brand.

The Egyptian competition watchdog, however, gave its nod to the impending merger subject to certain conditions. Per the conditions, if the companies decide to raise prices they will have to comply with an ECA-imposed cap. Moreover, the maximum value of the surge multiplier cannot exceed 2.5. Notably, surge pricing implies a situation where ride fares become more expensive than usual due to very high demand. Moreover, the number of trips to which such a pricing strategy is applicable cannot exceed 30% of the total trips. ECA has the right to intervene and lower the percentage.

Furthermore, the ECA prohibited the companies from deducting commissions from the drivers in excess of the current rate to protect the rights of the drivers. Moreover, in a bid to preserve competition in the local market, the ECA stated that the new competitors will have access to Uber’s mapping and trip data, among other things.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank & Key Picks

Uber carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the Zacks Internet-Services industry are Baidu (NASDAQ:BIDU) and Marchex (NASDAQ:MCHX) , both sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Shares of Baidu and Marchex have surged more than 23% and 21%, respectively, over the past three months.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Baidu, Inc. (BIDU): Free Stock Analysis Report

Marchex, Inc. (MCHX): Free Stock Analysis Report

Uber Technologies, Inc. (UBER): Free Stock Analysis Report

Lyft, Inc. (LYFT): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.